Targeting the IKKα/NF-κB Axis with SGEC-Derived Exosomal miR-23b-3p Rebalances Treg/Th17 Immunity in Sjögren’s Syndrome
Antioxidants & Redox Signaling · 2026
DOI: 10.1177/15230864261443868 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2026. Verfasst von Yan Cai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Radiology, Hospital of Stomatology, Jilin University, Changchun, People's Republic of China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, MicroRNAs, I-kappa B Kinase, NF-kappa B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Background
Sjögren’s syndrome (SS) is a systemic autoimmune disorder characterized by chronic inflammation, oxidative stress, and progressive salivary gland dysfunction. Current therapies remain limited in efficacy.
Aim
This study explored the regulatory effect of exosome (Exo)-transported miR-23b-3p on the IκB kinase alpha (IKKα)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling axis in SS.
Methods
Key SS-related microRNAs (miRNAs) were identified by integrating weighted gene co-expression network analysis with machine-learning-based transcriptomic profiling. Target genes and functional pathways were analyzed by bioinformatics methods. The direct binding between miR-23b and IKKα (CHUK) was validated by a dual-luciferase reporter assay. An in vitro SS cell model was established to examine the effects of miR-23b-3p on the IKKα/NF-κB pathway, oxidative stress, inflammation, and apoptosis. miR-23b-3p was loaded into salivary gland epithelial cell-derived Exos (SGEC-Exos) via electroporation. In vitro coculture experiments assessed reactive oxygen species (ROS) levels, inflammatory cytokines, Treg/Th17 balance, and cell apoptosis. In vivo effects were evaluated in NOD/Ltj mice by measuring salivary flow rate, histopathology, and expression of salivary-function-related proteins AQP5 and GPER.
Results
SGEC-Exos@miR-23b-3p significantly suppressed IKKα expression and NF-κB activation, reduced ROS production, and modulated immune responses by restoring the Treg/Th17 balance. It also inhibited apoptosis by decreasing Bax and caspase-3 expression and increasing Bcl-2 levels. These effects were partially reversed by reactivation of the IKKα/NF-κB pathway. In NOD/Ltj mice, SGEC-Exos@miR-23b-3p improved salivary flow, alleviated glandular pathology, and upregulated AQP5 and GPER expression.
Conclusions
SGEC-Exos@miR-23b-3p offers a translational approach to address oxidative stress, immune imbalance, and glandular injury in SS, highlighting the potential of Exo-based miRNA therapy. Antioxid. Redox Signal. 45, 376–396.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Radiology, Hospital of Stomatology, Jilin University, Changchun, People's Republic of China.
- 1nd ward of Oncology and Hematology Department, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
- Department of Hepatobiliary and Pancreatic Surgery, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
ORCID-Profile: Yan Cai
Zitieren
APA
Cai, Y., Wang, X., Feng, J., & E, C. (2026). Targeting the IKKα/NF-κB Axis with SGEC-Derived Exosomal miR-23b-3p Rebalances Treg/Th17 Immunity in Sjögren’s Syndrome. Antioxidants & Redox Signaling. https://doi.org/10.1177/15230864261443868
Vancouver
Cai Y, Wang X, Feng J, E C. Targeting the IKKα/NF-κB Axis with SGEC-Derived Exosomal miR-23b-3p Rebalances Treg/Th17 Immunity in Sjögren’s Syndrome. Antioxidants & Redox Signaling. 2026. doi:10.1177/15230864261443868
BibTeX
@article{Cai2026,
author = {Cai, Yan and Wang, Xianzhen and Feng, Jing and E, Changyong},
title = {Targeting the IKKα/NF-κB Axis with SGEC-Derived Exosomal miR-23b-3p Rebalances Treg/Th17 Immunity in Sjögren’s Syndrome},
journal = {Antioxidants & Redox Signaling},
year = {2026},
doi = {10.1177/15230864261443868}
}
EUVIMED